MedPath

Gerhard Rogler

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease

Phase 2
Completed
Conditions
Crohn's Disease
First Posted Date
2011-03-16
Last Posted Date
2015-05-28
Lead Sponsor
Gerhard Rogler
Target Recruit Count
3
Registration Number
NCT01316601

Study About the Effect of Doxycycline and Acetylcystein in the Treatment of CD-associated Fistulae

Not Applicable
Terminated
Conditions
Crohn's Disease
First Posted Date
2009-11-13
Last Posted Date
2014-12-04
Lead Sponsor
Gerhard Rogler
Target Recruit Count
20
Registration Number
NCT01012726

The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

Terminated
Conditions
Crohn's Disease
First Posted Date
2009-11-13
Last Posted Date
2014-12-04
Lead Sponsor
Gerhard Rogler
Target Recruit Count
34
Registration Number
NCT01012570
© Copyright 2025. All Rights Reserved by MedPath